B+
Bull case
25%
Probability
Target price
$6.50
+128.9% vs current
SRTS
Sensus HealthcareDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$4.60
+62.0% vs current
B-
Bear case
25%
Probability
Target price
$2.60
-8.5% vs current
AI sentiment snapshot
Latest data as of 2026-05-09
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Primary-source evidence is strong, but forward visibility is still limited. This is best treated as a cautious post-earnings monitoring memo rather than a clean bullish turn: the company provided a credible reimbursement-and-pipeline narrative, yet the reported quarter was weak and immediate sell-side revision evidence was not available in the checked sources. Using the packet anchor, the stock was $4.11 on May 7, 2026, and market data checked during this run showed shares around $3.08 afterward, consistent with a negative post-print reaction.
RankAlpha Sentiment Codex - 2026-05-09
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-31catalystQ1 2026 earnings reset is still being digestedHigh impact
The May 7, 2026 earnings release showed revenue down to $3.4 million from $8.3 million, 14 systems shipped versus 30 last year, no direct sales to the historically largest customer, and gross margin down to 29.2% from 52.2%, which supports a cautious near-term setup even after the initial selloff [#8-K-2026-05-07].
2026-08-07eventFair Deal site growth and recurring-revenue traction are the next operating proof pointsHigh impact
Q1 treatment volumes under the Fair Deal program increased 8% year over year, with 18 active sites and 9 pending activation, while Sensus Link and the financing offering are meant to support installed-base monetization; the next few quarters need to show that these initiatives offset lost large-customer volatility [#8-K-2026-05-07].
2026-12-31catalystNew CPT-code reimbursement framework could improve adoption quality later in 2026High impact
Management said dedicated CPT codes for SRT and IG-SRT became effective January 1, 2026 and are driving higher inquiry levels, stronger pipeline activity, improved physician economics, and broader customer diversification; the 10-K also states management expects the reimbursement increase to lift demand, but Q1 results show conversion is still early [#8-K-2026-05-07] [#10-K-2026-03-04].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-09 • Updated nightlySource: Internal modelMethodology